These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4203485)

  • 1. A human IgA-myeloma protein with anti-streptococcal hyaluronidase (ASH) activity.
    Videbaek A; Mansa B; Kjems E
    Scand J Haematol; 1973; 10(3):181-5. PubMed ID: 4203485
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple myeloma without initial paraproteins.
    Kim I; Harley JB; Weksler B
    Am J Med Sci; 1972 Oct; 264(4):267-75. PubMed ID: 4630526
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognosis of myelomatosis on treatment with prednisone and cytostatics.
    Hansen OP; Jessen B; Videbaek A
    Scand J Haematol; 1973; 10(4):282-90. PubMed ID: 4764610
    [No Abstract]   [Full Text] [Related]  

  • 4. The origin of monomeric and polymeric forms of IgA in man.
    Radl J; Schuit HR; Mestecky J; Hijmans W
    Adv Exp Med Biol; 1974; 45(0):57-65. PubMed ID: 4137994
    [No Abstract]   [Full Text] [Related]  

  • 5. [D-myeloma (observation of 8 cases)].
    Mokeeva RA; Verevkin IN; Piasik MV; Grigorian GD; Rybakova ME
    Probl Gematol Pereliv Krovi; 1981 Aug; 26(8):41-5. PubMed ID: 6795618
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prognosis in myelomatosis treated with prednisone and cytostatics].
    Hansen OP; Jessen B; Videbaek A
    Ugeskr Laeger; 1973 Jun; 135(23):1169-73. PubMed ID: 4757116
    [No Abstract]   [Full Text] [Related]  

  • 7. [IgA myeloma protein acting as an anti-stomach antibody in a gastrectomized patient].
    Micouin C; Groslambert P; Blanc D; Sotto JJ; Gintz B; Laquerriere C; Cabanel G
    Sem Hop; 1974 Apr; 50(19):1271-8. PubMed ID: 4373825
    [No Abstract]   [Full Text] [Related]  

  • 8. Incidence of monoclonal proteins in a Minnesota community with a cluster of multiple myeloma.
    Kyle RA; Finkelstein S; Elveback LR; Kurland LT
    Blood; 1972 Nov; 40(5):719-24. PubMed ID: 4627911
    [No Abstract]   [Full Text] [Related]  

  • 9. [Binding of beta-lipoprotein by an IgA paraprotein: an antigen-antibody reaction?].
    Noseda G; Bütler R; Schlumpf E; Brunner E; Riesen W
    Schweiz Med Wochenschr; 1971 Jun; 101(24):893-9. PubMed ID: 5004031
    [No Abstract]   [Full Text] [Related]  

  • 10. Vindesine therapy in melphalan-resistant multiple myeloma.
    Houwen B; Ockhuizen T; Marrink J; Nieweg HO
    Eur J Cancer (1965); 1981 Feb; 17(2):227-32. PubMed ID: 7262159
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cytomorphological, immunochemical and therapeutic aspects of multiple myeloma].
    Maroncelli P; Casalino C
    Minerva Med; 1973 Feb; 64(8):337-57. PubMed ID: 4120544
    [No Abstract]   [Full Text] [Related]  

  • 12. [Biclonal myeloma (IgG and IgA)].
    González Barón M; Martínez Fernández A; Durán A; Montero JM; Ordoñez A; Gasalla R
    Rev Clin Esp; 1973 Feb; 128(4):345-8. PubMed ID: 4700587
    [No Abstract]   [Full Text] [Related]  

  • 13. [Myelomatous paraproteinemia of the IgA or IgG type and blood lipids].
    Clerc M; Triquet A; Martine J
    Bull Soc Pathol Exot Filiales; 1974; 67(1):101-8. PubMed ID: 4219146
    [No Abstract]   [Full Text] [Related]  

  • 14. Types of size heterogeneity of IgA molecules isolated from myeloma and normal human serum.
    Fine JM; Lambin P; Frommel D
    Adv Exp Med Biol; 1974; 45(0):429-31. PubMed ID: 4213521
    [No Abstract]   [Full Text] [Related]  

  • 15. [Analysis of the results of treatment of multiple myeloma].
    Snigurowicz J; Rostkowska J; Kraj M; Mariańska B
    Acta Haematol Pol; 1979 Oct; 10(4):227-35. PubMed ID: 539350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of subclass-related F(ab)2, Fab-c and Fch fragments obtainined by short papain digestion of human IgG myeloma proteins.
    Michaelsen TE; Natvig JB
    Scand J Immunol; 1973; 2(3):299-312. PubMed ID: 4203731
    [No Abstract]   [Full Text] [Related]  

  • 17. IgE-type multiple myeloma with the late development of IgA2 kappa and plasma cell leukaemia.
    Chiu W; Pullon H; Woon ST; Oei P; The R; Ameratunga R
    Pathology; 2010 Jan; 42(1):82-4. PubMed ID: 20025486
    [No Abstract]   [Full Text] [Related]  

  • 18. A case of acute myelomonocytic leukaemia associated with myelomatosis.
    Parker AC
    Scand J Haematol; 1973; 11(4):257-60. PubMed ID: 4521505
    [No Abstract]   [Full Text] [Related]  

  • 19. Mouse IgA myeloma proteins with alpha chain deletions: a comparison with human alpha chains with deletions.
    Mushinski JF
    Adv Exp Med Biol; 1974; 45(0):223-7. PubMed ID: 4137853
    [No Abstract]   [Full Text] [Related]  

  • 20. The monoclonal nature of lymphocytes in multiple myeloma. Effects of therapy.
    Abdou NI; Abdou NL
    Ann Intern Med; 1975 Jul; 83(1):42-5. PubMed ID: 1096701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.